| Reagan-Udall Foundation

Read more about A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA)

Read more about Cognitive Impairment and Fatigue After Mild to Moderate COVID-19

Read more about SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Read more about Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain

Read more about Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects

Read more about Patients´ Mental and Physical Health After Covid-19 Treated in ICU in Sweden

Read more about Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

Read more about Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Read more about Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia

Read more about MIST Versus M-MIST for the Treatment of Intrabony Defects